8-K
Current Report
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001564590-22-024885
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading hrtx-8k_20220627.htm…